Sichuan Huiyu Pharmaceutical Co (SHSE:688553) Construction In Progress: ¥419 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688553 Sichuan Huiyu Pharmaceutical Co Ltd SHSE:688553
65 GF Score
Price ¥10.27
GF Value ¥9.85
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Sichuan Huiyu Pharmaceutical Co Construction In Progress?

Sichuan Huiyu Pharmaceutical Co SHSE:688553 -2.00% 65 Construction In Progress is ¥419 Mil as of Mar. 2026. GuruFocus rates SHSE:688553 with a GF Score™ of 65/100 and a GF Value™ of ¥9.85 (Fairly Valued). The stock has 6 warning signs investors should review.

Sichuan Huiyu Pharmaceutical Co's quarterly construction in progress declined from Sep. 2025 (¥514 Mil) to Dec. 2025 (¥414 Mil) but then increased from Dec. 2025 (¥414 Mil) to Mar. 2026 (¥419 Mil).

Sichuan Huiyu Pharmaceutical Co's annual construction in progress declined from Dec. 2023 (¥768 Mil) to Dec. 2024 (¥529 Mil) and declined from Dec. 2024 (¥529 Mil) to Dec. 2025 (¥414 Mil).

Sichuan Huiyu Pharmaceutical Co Construction In Progress Historical Data

* Premium members only.

The historical data trend for Sichuan Huiyu Pharmaceutical Co's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sichuan Huiyu Pharmaceutical Co Construction In Progress Chart

Sichuan Huiyu Pharmaceutical Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Construction In Progress
Get a 7-Day Free Trial Premium Member Only 365.65 695.82 768.43 528.72 414.47

Sichuan Huiyu Pharmaceutical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 504.66 508.19 513.79 414.47 418.95
SHSE:688553
65GF Score
Sichuan Huiyu Pharmaceutical Co Ltd SHSE:688553
Construction In Progress is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sichuan Huiyu Pharmaceutical Co Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

What does a Construction In Progress of ¥419 Mil mean?
Sichuan Huiyu Pharmaceutical Co (SHSE:688553) has a Construction In Progress of ¥419 Mil as of Mar. 2026. Construction in Progress records the amount of construction work that is not complete. View historical data on Sichuan Huiyu Pharmaceutical Co and its competitors.
Is Sichuan Huiyu Pharmaceutical Co's Construction In Progress too high?
Sichuan Huiyu Pharmaceutical Co's current Construction In Progress is ¥419 Mil. Overall, Sichuan Huiyu Pharmaceutical Co has a GF Score™ of 65/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Sichuan Huiyu Pharmaceutical Co's Construction In Progress compare to ZTS?
Sichuan Huiyu Pharmaceutical Co's Construction In Progress of ¥419 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for a Drug Manufacturers company?
A good Construction In Progress depends on the Drug Manufacturers industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on Sichuan Huiyu Pharmaceutical Co and its competitors. Sichuan Huiyu Pharmaceutical Co's current Construction In Progress is ¥419 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sichuan Huiyu Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Sichuan Huiyu Pharmaceutical Co (SHSE:688553) is currently considered Fairly Valued. The stock's GF Value™ is ¥9.85, compared to a current price of ¥10.27 — trading 4.3% above its estimated fair value. The current Construction In Progress is ¥419 Mil. Sichuan Huiyu Pharmaceutical Co's overall GF Score™ is 65/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For Sichuan Huiyu Pharmaceutical Co (SHSE:688553), the current Construction In Progress is ¥419 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sichuan Huiyu Pharmaceutical Co (SHSE:688553) Overvalued in 2026?

Based on GuruFocus' analysis, Sichuan Huiyu Pharmaceutical Co stock appears to be overvalued. The current stock price of ¥10.27 is trading 4.3% above its estimated GF Value™ of ¥9.85. GuruFocus considers Sichuan Huiyu Pharmaceutical Co to be Fairly Valued.

Key valuation signals for SHSE:688553:

  • Construction In Progress: ¥419 Mil
  • GF Value™: ¥9.85 vs. price of ¥10.27 (4.3% above fair value)
  • GF Score™: 65/100 with 6 warning signs

No single metric tells the full story. See the SHSE:688553 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sichuan Huiyu Pharmaceutical Co Business Description

Address No.333 Hanyang Road, Building 3, Shizhong District, Sichuan Province, Neijiang, CHN, 641000
Sichuan Huiyu Pharmaceutical Co Ltd is engaged in the research and development, production and sales of anti-tumor and injection drugs.
65GF Score

Get the complete analysis for SHSE:688553

Construction In Progress is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥10.27
Price
¥9.85
GF Value